332 related articles for article (PubMed ID: 20172140)
1. Use of oral budesonide in the management of protein-losing enteropathy after the Fontan operation.
Thacker D; Patel A; Dodds K; Goldberg DJ; Semeao E; Rychik J
Ann Thorac Surg; 2010 Mar; 89(3):837-42. PubMed ID: 20172140
[TBL] [Abstract][Full Text] [Related]
2. The use of oral budesonide in adolescents and adults with protein-losing enteropathy after the Fontan operation.
John AS; Driscoll DJ; Warnes CA; Phillips SD; Cetta F
Ann Thorac Surg; 2011 Oct; 92(4):1451-6. PubMed ID: 21784410
[TBL] [Abstract][Full Text] [Related]
3. Oral budesonide as a therapy for protein-losing enteropathy in children after the Fontan operation.
Gursu HA; Erdogan I; Varan B; Oktay A; Ozcay F; Ozkan M; Aslamaci S
J Card Surg; 2014 Sep; 29(5):712-6. PubMed ID: 24889258
[TBL] [Abstract][Full Text] [Related]
4. Oral budesonide as a therapy for protein-losing enteropathy in patients having undergone Fontan palliation.
Turner Z; Lanford L; Webber S
Congenit Heart Dis; 2012; 7(1):24-30. PubMed ID: 22129195
[TBL] [Abstract][Full Text] [Related]
5. Reversal of protein-losing enteropathy with calcium replacement in a patient after Fontan operation.
Kim SJ; Park IS; Song JY; Lee JY; Shim WS
Ann Thorac Surg; 2004 Apr; 77(4):1456-7. PubMed ID: 15063295
[TBL] [Abstract][Full Text] [Related]
6. Protein-losing enteropathy after fontan operation: investigations into possible pathophysiologic mechanisms.
Ostrow AM; Freeze H; Rychik J
Ann Thorac Surg; 2006 Aug; 82(2):695-700. PubMed ID: 16863787
[TBL] [Abstract][Full Text] [Related]
7. Protein-losing enteropathy after the Fontan operation: clinical analysis of nine cases.
Lin WS; Hwang MS; Chung HT; Chu JJ; Lai MW; Yang JS; Huang SC; Huang JL; Su WJ
Chang Gung Med J; 2006; 29(5):505-12. PubMed ID: 17214396
[TBL] [Abstract][Full Text] [Related]
8. Results of transcatheter Fontan fenestration to treat protein losing enteropathy.
Vyas H; Driscoll DJ; Cabalka AK; Cetta F; Hagler DJ
Catheter Cardiovasc Interv; 2007 Mar; 69(4):584-9. PubMed ID: 17323361
[TBL] [Abstract][Full Text] [Related]
9. Treatment strategies for protein-losing enteropathy in Fontan-palliated patients.
Schleiger A; Ovroutski S; Peters B; Schubert S; Photiadis J; Berger F; Kramer P
Cardiol Young; 2020 May; 30(5):698-709. PubMed ID: 32364090
[TBL] [Abstract][Full Text] [Related]
10. Resolution of protein-losing enteropathy and normalization of mesenteric Doppler flow with sildenafil after Fontan.
Uzun O; Wong JK; Bhole V; Stumper O
Ann Thorac Surg; 2006 Dec; 82(6):e39-40. PubMed ID: 17126088
[TBL] [Abstract][Full Text] [Related]
11. Resolution of protein-losing enteropathy with low-molecular weight heparin in an adult patient with Fontan palliation.
Bhagirath KM; Tam JW
Ann Thorac Surg; 2007 Dec; 84(6):2110-2. PubMed ID: 18036954
[TBL] [Abstract][Full Text] [Related]
12. Legionella pneumonia and bacteraemia in association with protein-losing enteropathy after Fontan operation.
Cheung YF; Leung MP; Yuen KY
J Infect; 2001 Apr; 42(3):206-7. PubMed ID: 11545554
[TBL] [Abstract][Full Text] [Related]
13. Use of oral budesonide in the management of protein-losing enteropathy due to restrictive cardiomyopathy.
Gursu HA; Varan B; Erdogan I
Cardiol Young; 2014 Aug; 24(4):764-6. PubMed ID: 24029379
[TBL] [Abstract][Full Text] [Related]
14. The use of octreotide to successfully treat protein-losing enteropathy following the Fontan operation.
John AS; Phillips SD; Driscoll DJ; Warnes CA; Cetta F
Congenit Heart Dis; 2011; 6(6):653-6. PubMed ID: 21545466
[TBL] [Abstract][Full Text] [Related]
15. Protein-losing enteropathy after the total cavopulmonary connection: impact of intravenous immunoglobulin.
Zaupper LB; Nielsen BW; Herlin T
Congenit Heart Dis; 2011; 6(6):624-9. PubMed ID: 22010984
[TBL] [Abstract][Full Text] [Related]
16. Protein-losing enteropathy after Fontan operation: resolution after baffle fenestration.
Jacobs ML; Rychik J; Byrum CJ; Norwood WI
Ann Thorac Surg; 1996 Jan; 61(1):206-8. PubMed ID: 8561554
[TBL] [Abstract][Full Text] [Related]
17. Protein-losing enteropathy after Fontan operation.
Rychik J
Congenit Heart Dis; 2007; 2(5):288-300. PubMed ID: 18377444
[TBL] [Abstract][Full Text] [Related]
18. Outcome of protein-losing gastroenteropathy in systemic lupus erythematosus treated with prednisolone and azathioprine.
Mok CC; Ying KY; Mak A; To CH; Szeto ML
Rheumatology (Oxford); 2006 Apr; 45(4):425-9. PubMed ID: 16234272
[TBL] [Abstract][Full Text] [Related]
19. An unusual treatment for protein losing enteropathy.
Windram JD; Clift PF; Speakman J; Thorne SA
Congenit Heart Dis; 2011; 6(3):253-6. PubMed ID: 21418528
[TBL] [Abstract][Full Text] [Related]
20. Oral budesonide treatment for protein-losing enteropathy in Fontan-palliated patients.
Schumacher KR; Cools M; Goldstein BH; Ioffe-Dahan V; King K; Gaffney D; Russell MW
Pediatr Cardiol; 2011 Oct; 32(7):966-71. PubMed ID: 21660539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
